Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Continual reassessment method (CRM)].

N Ishizuka1

  • 1Division of Cancer Information & Epidemiology, National Cancer Center Research Institute.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|September 2, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Investigating the timing and site of recurrence for ovarian clear cell carcinoma: Analysis of the JGOG/GCIG trial-JGOG 3017-A3.

Gynecologic oncology·2024
Same author

Staging laparoscopy for pancreatic cancer using intraoperative ultrasonography and fluorescence imaging: the SLING trial.

The British journal of surgery·2021
Same author

Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2019
Same author

Oesophagectomy with or without supraclavicular lymphadenectomy after neoadjuvant treatment for squamous cell carcinoma of the oesophagus.

The British journal of surgery·2018
Same author

Octadecylsilylated porous silica rods as separation media for reversed-phase liquid chromatography.

Analytical chemistry·2011
Same author

Axonal trajectory of single group Ia and Ib fibers in the cat spinal cord.

Neuroscience letters·2009

The continual reassessment method (CRM) offers an ethical and scientific alternative to traditional phase I cancer trial designs. This Bayesian approach sequentially updates dose-toxicity relationships for better patient outcomes.

Area of Science:

  • Oncology
  • Biostatistics
  • Clinical Trial Design

Context:

  • Phase I clinical trials in cancer are critical for determining safe and effective drug dosages.
  • Traditional cohort designs present ethical concerns and may not efficiently explore the dose-toxicity relationship.
  • Balancing ethical considerations with the scientific need for precise dose-finding is paramount.

Purpose:

  • To introduce the Continual Reassessment Method (CRM) as an alternative to traditional cohort designs for phase I cancer trials.
  • To highlight the CRM's sequential dose selection based on accumulating patient response data.
  • To explain the Bayesian updating mechanism for refining dose-toxicity relationships.

Summary:

  • The CRM is a sequential design that adapts dose levels for subsequent patients based on observed toxicity data.

Related Experiment Videos

  • It utilizes Bayesian statistical methods to continuously update the estimated dose-toxicity curve.
  • This approach aims to identify the maximum tolerated dose more efficiently and ethically compared to traditional methods.

    • Impact:

    • The CRM can improve the efficiency and ethical conduct of phase I cancer clinical trials.
    • It allows for a more precise estimation of the maximum tolerated dose, potentially benefiting future trial phases.
    • Understanding the CRM's advantages and practical limitations is crucial for its successful implementation in clinical research.